These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20452133)

  • 1. Pelvic lymph node status assessed by 18F-fluorodeoxyglucose positron emission tomography predicts low-risk group for distant recurrence in locally advanced cervical cancer: a prospective study.
    Kang S; Park JY; Lim MC; Song YJ; Park SH; Kim SK; Chung DC; Seo SS; Kim JY; Park SY
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):788-93. PubMed ID: 20452133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
    Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
    Cancer; 2010 Mar; 116(6):1469-75. PubMed ID: 20108309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
    Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S
    Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
    Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
    Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
    Yoon MS; Ahn SJ; Nah BS; Chung WK; Song HC; Yoo SW; Song JY; Jeong JU; Nam TK
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e491-7. PubMed ID: 22818418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
    Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
    J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False negative rate at
    Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
    BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.
    Nakamura K; Okumura Y; Kodama J; Hongo A; Kanazawa S; Hiramatsu Y
    Gynecol Oncol; 2010 Oct; 119(1):81-6. PubMed ID: 20580064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
    Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT
    Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.
    Yeh LS; Hung YC; Shen YY; Kao CH; Lin CC; Lee CC
    Oncol Rep; 2002; 9(6):1289-92. PubMed ID: 12375036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
    Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer.
    Small W; Vern TZ; Rademaker A; Nemcek A; Spies S; Schink JC; Singh DK; Lurain JR
    Am J Clin Oncol; 2010 Feb; 33(1):89-93. PubMed ID: 19730352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
    Monteil J; Maubon A; Leobon S; Roux S; Marin B; Renaudie J; Genet D; Fermeaux V; Aubard Y; Tubiana-Mathieu N
    Anticancer Res; 2011 Nov; 31(11):3865-71. PubMed ID: 22110211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
    Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of [
    Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
    Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.